Galera Therapeutics Inc (GRTX)

$0.03 0.00 (-4.56%)
Market Cap 2.15M
Revenue (ttm) 0.00
Net Income (ttm) -18.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 300
Avg Vol 49,838
Day's Range N/A - N/A
Shares Out 75.46M
Stochastic %K 15%
Beta 1.87
Analysts Strong Buy
Price Target $0.25

Company Profile

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese,...

Industry: Biotechnology
Sector: Healthcare
Phone: 610 725 1500
Address:
101 Lindenwood Drive, Suite 225, Malvern, United States
AlphaTuna
AlphaTuna Jun. 30 at 10:28 PM
Lowest Volume Rated General Stocks Per 6/30/2025’s Close: 1 – $SVMFF 2 – $RYES 3 – $INBP 4 – $SRAFF 5 – $GRTX 6 – $CPFXF 7 – $MVNC 8 – $SPAUF 9 – $PAIYY 10 – $FCSMF https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-6-30-2025/
0 · Reply
dareveerunner
dareveerunner May. 17 at 3:53 PM
$GRTX this is a done deal..move on..
0 · Reply
Delfan02
Delfan02 May. 12 at 8:48 PM
$GRTX 5,121 watchers yet no conversations....
1 · Reply
d_risk
d_risk Apr. 1 at 9:06 PM
$GRTX - Galera Therapeutics, Inc. - 10K - Updated Risk Factors GRTX's 2025 10-K Risk Factors reveal ongoing challenges with unapproved products, funding needs, reliance on third parties, and integration risks from the Nova Acquisition. New risks include potential stockholder dilution, regulatory changes, and increased compliance costs. #Biotechnology #StockholderDilution #AcquisitionIntegration #RegulatoryRisks #FundingChallenges 🟢 Added 🟠 Removed https://d-risk.ai/GRTX/10-K/2025-03-31
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 27 at 1:08 PM
$GRTX Rough road for GRTX. FDA rejection killed momentum. Looks like strategic alternatives are last hope. Management needs to pull a rabbit out of the hat or this could be end game. Watching closely for any partnership news. solid article: https://beyondspx.com/article/galera-therapeutics-grtx-navigating-through-challenges-towards-a-promising-future
0 · Reply
Gj64
Gj64 Mar. 4 at 8:42 AM
$GRTX https://investors.galeratx.com/financial-information/sec-filings
0 · Reply
Q12021Dreaming
Q12021Dreaming Feb. 19 at 7:00 PM
$GRTX I like reversals 🍀🐂🍀
0 · Reply
Janestockaddiction
Janestockaddiction Feb. 18 at 1:13 AM
$GRTX Notably, in August 2024, Galera's board approved a complete liquidation and dissolution of the company. GLOBENEWSWIRE.COM This significant development could impact the company's future operations and stock performance. Given these mixed signals and significant corporate changes, it's crucial to conduct thorough research and consult with a financial advisor before making investment decisions regarding GRTX.
0 · Reply
atreus57
atreus57 Jan. 28 at 3:55 PM
$LXRX overall good news... stable growth, should enter a phase of rapid sustainable growth... $IBRX $EFTR $GRTX seems like $LXRX will grow soon and will have profitability soon... very good job!
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 25 at 7:02 AM
$GRTX Galera Therapeutics, Inc. (NASDAQ:GRTX): Navigating Challenges and Exploring Strategic Alternatives https://beyondspx.com/article/galera-therapeutics-inc-grtx-charting-a-path-through-uncertainty
0 · Reply
Latest News on GRTX
No data available.
AlphaTuna
AlphaTuna Jun. 30 at 10:28 PM
Lowest Volume Rated General Stocks Per 6/30/2025’s Close: 1 – $SVMFF 2 – $RYES 3 – $INBP 4 – $SRAFF 5 – $GRTX 6 – $CPFXF 7 – $MVNC 8 – $SPAUF 9 – $PAIYY 10 – $FCSMF https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-6-30-2025/
0 · Reply
dareveerunner
dareveerunner May. 17 at 3:53 PM
$GRTX this is a done deal..move on..
0 · Reply
Delfan02
Delfan02 May. 12 at 8:48 PM
$GRTX 5,121 watchers yet no conversations....
1 · Reply
d_risk
d_risk Apr. 1 at 9:06 PM
$GRTX - Galera Therapeutics, Inc. - 10K - Updated Risk Factors GRTX's 2025 10-K Risk Factors reveal ongoing challenges with unapproved products, funding needs, reliance on third parties, and integration risks from the Nova Acquisition. New risks include potential stockholder dilution, regulatory changes, and increased compliance costs. #Biotechnology #StockholderDilution #AcquisitionIntegration #RegulatoryRisks #FundingChallenges 🟢 Added 🟠 Removed https://d-risk.ai/GRTX/10-K/2025-03-31
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 27 at 1:08 PM
$GRTX Rough road for GRTX. FDA rejection killed momentum. Looks like strategic alternatives are last hope. Management needs to pull a rabbit out of the hat or this could be end game. Watching closely for any partnership news. solid article: https://beyondspx.com/article/galera-therapeutics-grtx-navigating-through-challenges-towards-a-promising-future
0 · Reply
Gj64
Gj64 Mar. 4 at 8:42 AM
$GRTX https://investors.galeratx.com/financial-information/sec-filings
0 · Reply
Q12021Dreaming
Q12021Dreaming Feb. 19 at 7:00 PM
$GRTX I like reversals 🍀🐂🍀
0 · Reply
Janestockaddiction
Janestockaddiction Feb. 18 at 1:13 AM
$GRTX Notably, in August 2024, Galera's board approved a complete liquidation and dissolution of the company. GLOBENEWSWIRE.COM This significant development could impact the company's future operations and stock performance. Given these mixed signals and significant corporate changes, it's crucial to conduct thorough research and consult with a financial advisor before making investment decisions regarding GRTX.
0 · Reply
atreus57
atreus57 Jan. 28 at 3:55 PM
$LXRX overall good news... stable growth, should enter a phase of rapid sustainable growth... $IBRX $EFTR $GRTX seems like $LXRX will grow soon and will have profitability soon... very good job!
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 25 at 7:02 AM
$GRTX Galera Therapeutics, Inc. (NASDAQ:GRTX): Navigating Challenges and Exploring Strategic Alternatives https://beyondspx.com/article/galera-therapeutics-inc-grtx-charting-a-path-through-uncertainty
0 · Reply
tntz_79
tntz_79 Jan. 13 at 5:01 PM
$GRTX boring
0 · Reply
StLux
StLux Jan. 4 at 11:08 AM
$GRTX who knows...it might our Nancy Pelosi. What if it's really her in disguised 🥸 🤔 😳 👀 .
0 · Reply
luciferr92
luciferr92 Jan. 4 at 4:52 AM
$GRTX Oh, if she were Nancy Felosy, not Nancy Chang
0 · Reply